SCHEMBL8485284

SCHEMBL8485284

Cn1cncc1S(=O)(=O)C1CCNCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
GABRA1 P14867 1/20 0.35
TSHR P16473 1/20 0.35
GABRG2 P18507 1/20 0.35
NFKB1 P19838 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRA6 Q16445 1/20 0.35
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
PLAT P00750 1/20 0.32
CNR2 P34972 1/20 0.32
JAK1 P23458 1/20 0.32
MAP4K3 Q8IVH8 1/20 0.31
NAMPT P43490 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24153513 0.70 CNR2 (0.37) CYP11B1CYP11B2LMNACYP3A4GABRA1
Hydrochloric Acid SCHEMBL26109215 0.69 CNR2 (0.37) CYP11B1CYP11B2LMNACYP3A4GABRA1
SCHEMBL250225 0.68 PLAT (0.42) GABRA1PLATHRH3
SCHEMBL13006988 0.68 IDO1 (0.35)
SCHEMBL2702083 0.68 IDO1 (0.36) JAK1
Hydrochloric Acid SCHEMBL27035780 0.67 PLAT (0.41) GABRA1PLATHRH3
SCHEMBL7468382 0.66 IDO1 (0.35) GABRA5
SCHEMBL999067 0.66 IDO1 (0.33)
Hydrochloric Acid SCHEMBL4575262 0.65 IDO1 (0.33)
SCHEMBL12017803 0.65 HTR6 (0.46) LMNACYP3A4GABRA1TSHRGABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed